Lupus anticoagulants/antiphospholipid-protein antibodies: The great imposters

Lupus

Volumn 5, Issue 5, 1996, Pages 431-435

  Triplett, D A ^a  

^a BALL MEMORIAL HOSPITAL   (United States)

Author keywords

Anticardiolipin antibodies; APA syndrome; Lupus anticoagulants; Thrombosis

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; LIPOCORTIN 5; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; PROTHROMBIN;

ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; CONFERENCE PAPER; ENZYME LINKED IMMUNOSORBENT ASSAY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; THROMBOEMBOLISM;

EID: 0029804631     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339600500519     Document Type: Conference Paper

References (36)

1. Triplett DA. Antiphospholipid-protein antibodies: laboratory detection and clinical relevance. Thromb Res 1995; 78: 1-31
2. Roubey RAS. Autoantibodies to phospholipid plasma proteins: a new view of lupus anticoagulants and other 'antiphospholipid' autoantibodies. Blood 1994; 84: 2854-2867
3. Galli M et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma cofactor. Lancet 1990; 335: 1544-1547
4. 2 Glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87: 4120-4124
5. 2 Glycoprotein I in the absence of phospholipid. J Immunol 1995; 154: 954-960
6. Bevers EM et al. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only but to a complex of lipid bound prothrombin. Thromb Haemost 1991; 66: 629-632
7. Conley CL, Hartmann RC. A hemorrhagic disorder caused by circulating anticoagulants in patients with disseminated lupus erythematosus. J Lab Clin Invest 1952; 31: 621-622
8. Fleck RA, Rapaport SI, Rao LVM. Antiprothrombin antibodies and the lupus anticoagulant. Blood 1988; 72: 512-519
9. Triplett DA. Protein clinical presentation of antiphospholipid-protein antibodies (APA). Thromb Haemost 1995; 74: 329-337
10. Bowie EJW, Thompson JH, Pascuzzi CA, Owen CA. Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. J Lab Clin Med 1963; 62: 416-430
11. Harris EN et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; 2: 1211-1214
12. Hughes GRV. The antiphospholipid syndrome: ten years on. Lancet 1993; 342: 341-344
13. Triplett DA. Antiphospholipid antibodies and thrombosis: a consequence, coincidence or cause?. Arch Pathol Lab Med 1993; 117: 77-88
14. Triplett DA. Antiphospholipid antibodies and recurrent pregnancy loss. Am J Reprod Immunol 1989; 20: 52-67
15. Chong BH, Brighton TC, Chesterman CN. Antiphospholipid antibodies and platelets. Semin Thromb Hemost 1995; 21: 76-84
16. Lockwood CJ, Rand JH. The immunobiology and obstetrical consequences of antiphospholipid antibodies. Obstet Gynecol Surv 1994; 49: 432-441
17. Shapiro SS. The lupus anticoagulant/antiphospholipid syndrome. Ann Rev Med 1995; 47: 533-553
18. Brenner B, Blumenfeld Z, Markiewicz W, Reisner SA. Cardiac involvement in patients with primary antiphospholipid syndrome. J Am Coll Cardiol 1991; 18: 931-936
19. Matthey F, Walshe K, Mackie JJ, Machin SJ. Familial occurrence of the antiphospholipid syndrome. J Clin Pathol 1989; 42: 495-497
20. Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation 1996; 93: 1579-1587
21. Roldan CA et al. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. J Am Coll Cardiol 1992; 20: 1127-1134
22. Lavalle C et al. Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies. J Rheumatol 1990; 17: 34-37
23. Kalashnikova LA, Nasonov EL, Kushckhacua AE, Grachcua LA. Anticardiolipin antibodies in Sneddon's syndrome. Neurology 1990; 40: 464-467
24. Becker JC, Winlder B, Klingert S, Brocker EB. Antiphospholipid syndrome associated with immuno-therapy for patients with melanoma. Cancer 1994; 73: 1621-1624
25. Carreno L et al. Anticardiolipin antibodies in pediatric patients with human immunodeficiency virus J Rheumatol 1994; 21: 1344-1346
26. el Saeed A et al. The development of antiphospholipid antibodies in haemophilia is linked to infection with hepatitis C. Br J Haematol 1994; 88: 845-848
27. Galli M et al Interaction between platelets and lupus anticoagulant. Eur J Haematol 1988; 41: 88-94
28. Jouhikainen T et al. Platelet autoantibodies detected by immunoblotting in systemic lupus erythematosus: association with the lupus anticoagulant and with history of thrombosis and thrombocytopenia. Eur J Hematol 1990; 44: 234-239
29. Facer CA, Agiostratidou G. High levels of anti-phospholipid antibodies in uncomplicated and severe plasmodium falliparum and P. vivax malaria. Clin Exp Immunol 1994; 95: 304-309
30. Roussi J, Roisin JP, Goguel A. Lupus anticoagulants first French interlaboratory etalonorme survey. Am J Clin Pathol 1996; 105: 788-793
31. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 1995; 74: 1185-1190
32. Lee MT et al. Transient hemorrhagic diathesis associated with an inhibitor of prothrombin with lupus anticoagulant in a 11/2 year old girl: report of a case and review of the literature. Am J Haematol 1996; 51: 307-314
33. Jaeger U et al. Transient lupus anticoagulant associated with hypoprothrombinemia and factor XII deficiency following adenovirus infection. Ann Haematol 1993; 67: 95-99
34. Arnout J. The pathogenesis of the antiphospholipid syndrome: a hypothesis based on parallelisms with heparin induced thrombocytopenia. Thromb Haemost 1996; 75: 536-541
35. Triplett DA. Antiphospholipid antibodies, lupus anticoagulants and thromboembolic disease. Haematologica 1995; 80: 122-126
36. Oosting JD et al. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C or protein S. An explanation for their pathogenic mechanism. Blood 1993; 81: 2618-2625